Department of Nephrology, Iizuka Hospital, Iizuka, Fukuoka, Japan.
Department of Nephrology, Iizuka Hospital, Iizuka, Fukuoka, Japan
BMJ Open. 2022 Oct 7;12(10):e058666. doi: 10.1136/bmjopen-2021-058666.
Elevated baseline serum alkaline phosphatase (ALP) may correlate with higher medium-term to long-term mortality in the general population and in patients with chronic kidney disease. However, few data are available on the association between serum ALP and the short-term prognosis of patients on haemodialysis (HD). We verified the association of ALP levels and bacteraemia or death in maintenance HD patients suspected of bacteraemia in an outpatient setting.
We analysed 315 consecutive HD patients suspected of having bacteraemia with two sets of blood culture drawn on admission.
Admission to two tertiary-care university medical centres from January 2013 to December 2015.
Consecutive cases on maintenance HD aged≥18 years. Cases of hospitalised patients who had been transferred from another hospital, had a dialysis vintage<2 months, were also undergoing peritoneal dialysis, and/or were receiving HD less than once a week were excluded.
Primary outcome measure was bacteraemia and secondary outcome was in-hospital death.
Among 315 cases included in the study, 187 had baseline-measured ALP levels, with a cut-off value on ROC analysis of 360 U/L (Area Under the Curve (AUC) 0.60, sensitivity 0.49, specificity 0.76). In multivariate analysis, there was a statistically significant association between a higher ALP in hospital visit and bacteraemia (OR: 2.37, 95% CI: 1.17 to 4.83). However, there were no statistically significant associations between higher ALP and in-hospital death (OR: 1.20, 95% CI: 0.57 to 2.54). A sensitivity analysis of 187 patients with no missing ALP values also demonstrated a significant association between elevated ALP and bacteraemia, but no significant association between ALP and in-hospital death.
Elevated ALP is a predictor of bacteraemia. In HD patients suspected of bacteraemia in outpatient settings, increased ALP levels were associated with increased likelihood of confirmed disease.
在普通人群和慢性肾脏病患者中,基线血清碱性磷酸酶(ALP)升高可能与中、长期死亡率升高相关。然而,关于血清 ALP 与血液透析(HD)患者短期预后之间的关系,数据较少。我们在门诊疑似菌血症的维持性 HD 患者中验证了 ALP 水平与菌血症或死亡的关系。
我们分析了 2013 年 1 月至 2015 年 12 月期间在两家三级大学医学中心住院的 315 例连续疑似菌血症的 HD 患者的两套血培养结果。
两家三级大学医学中心。
年龄≥18 岁、维持性 HD 患者。排除住院患者,其已从另一家医院转来、透析龄<2 个月、同时接受腹膜透析、或每周接受 HD 治疗<1 次。
主要结局测量是菌血症,次要结局测量是院内死亡。
在纳入的 315 例患者中,有 187 例基线测量的 ALP 水平,ROC 分析的截断值为 360 U/L(曲线下面积(AUC)为 0.60,敏感性为 0.49,特异性为 0.76)。多变量分析显示,就诊时 ALP 升高与菌血症有统计学显著关联(OR:2.37,95%CI:1.17 至 4.83)。然而,ALP 升高与院内死亡之间无统计学显著关联(OR:1.20,95%CI:0.57 至 2.54)。对 187 例无缺失 ALP 值的患者进行的敏感性分析也表明,ALP 升高与菌血症之间存在显著关联,但与院内死亡之间无显著关联。
升高的 ALP 是菌血症的预测指标。在门诊疑似菌血症的 HD 患者中,ALP 水平升高与确诊疾病的可能性增加相关。